Former pharma executive who joined HHS to help lower drug

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28
199
Former pharma executive who joined HHS to help lower drug prices found bludgeoned to death in D.C. … ruled “suicide”

That is how hawks Deep State works, lovely people murder a man trying to lower drug prices and The Chief Medical Examiner’ covers it up

https://www.naturalnews.com/2018-11-18-former...icide.html

former executive for Pfizer, recently tasked with joining HHS to help reduce the prices of Big Pharma’s monopoly prescription medications, was found bludgeoned to death outside his Washington D.C. apartment. Local police ruled the death of Daniel Best a suicide, raising immediate questions about how an individual can bludgeon himself to death with multiple blows.

“The city’s Office of the Chief Medical Examiner on Thursday said Best died from “multiple blunt force injuries” and it ruled his death a suicide. It would not release further information,” reports Cleveland.com. The news website also reports:

In announcing his death, HHS Secretary Alex Azar said the 49-year-old former CVSHealth and Pfizer Pharmaceuticals executive agreed to work at HHS “out of a desire to serve the American people by making health care more affordable.”

Obviously a murder… and a cover-up
Not everybody is buying the official explanation. “The Chief Medical Examiner’s verdict raised questions among the health community, with many people refusing to believe Best killed himself by repeatedly hitting himself with a blunt object until he died,” reports NeoNettle.com.

NeoNettle also reports:

According to Washington, D.C. Police, Best was found “unresponsive” near the garage door exit of an apartment building in D.C.’s Navy Yard neighborhood at 5:25 a.m. on November 1, and was pronounced dead by medical personnel who responded to the scene.

To believe that Daniel Best murdered himself strains any shred of credibility. If a man wanted to kill himself, why would he attempt to do it with a blunt object requiring multiple strikes? And why would he choose to do it just outside the garage exit door of an apartment complex rather than inside his own living room?

Support our mission to keep you informed: Discover the extraordinary benefits of turmeric gummy bears and organic "turmeric gold" liquid extract, both laboratory tested for heavy metals, microbiology and safety. Naturally high in potent curcuminoids. Delicious formulations. All purchases support this website (as well as your good health). See availability here.

We must also consider who stands to benefit from interfering with a process that might end Big Pharma’s drug price monopoly. The corrupt pharmaceutical industry, which routinely bribes doctors, pushes fake science and uses human beings as guinea pigs for medical experiments, also murders children with toxic vaccines. (Over 100,000 U.S. children are maimed or killed by vaccines each year.) Why would they hesitate to kill one man who might stand in their way of continued ridiculous profits?

This is another big reason why all those who criticize Big Pharma should carry one or more concealed firearms (and be prepared to fire at multiple attackers as needed). Yes, the drug cartels literally have people murdered. I’ve been death-threated so many times, I’ve lost count…

Why Big Pharma is willing to murder people to protect its scandalous profit model
Big Pharma is a functioning drug cartel that enjoys anti-free market monopoly protections enforced by corrupt FDA and FTC regulators.

The purpose of the pharmaceutical industry’s entire existence is to extract the maximum amount of money from the U.S. economy by pretending to make sick people healthier through the widespread consumption of high-profit pharmaceutical medications. However, the profit model of the industry is almost entirely based on convincing healthy people they need lifelong medications to be healthy. This requires, of course, the “marketing of disease” that scares people into thinking they need drugs for completely normal physiological conditions (such as feeling depressed from time to time, which is a normal human experience).

The more medications people take, the sicker they become, requiring yet more secondary medications to “treat” the negative health symptoms caused by the primary medications. The real profit model of the pharmaceutical industry is to keep people sick, then charge them monopoly prices for dangerous medications that utterly fail to achieve any lasting improvement in health. Any effort to reduce drug prices or monopoly profits will be met with extreme resistance… and perhaps acts of murder funded by the industry itself.

The statin drug / cholesterol scam, all by itself, is a multi-decade long quack science medical scam that has extracted nearly half a trillion dollars from the world economy by pretending that cholesterol is a “disease.” In truth, statin drugs cause accelerated aging, brain damage, diabetes, extreme muscle fatigue and a long list of other serious health complications that demand further medication. That’s why statin drugs are known as gateway drugs that ultimately recruit lifelong patients to boost Big Pharma’s profits. There’s also zero evidence that statin drugs improve patient survival at all.

The entire sham is rooted in utterly faked science, ghost-written “science” papers, the bribery of regulatory officials and the incessant propaganda indoctrination of med schools with Big Pharma brainwashing materials. Statin-pushing quacks like Steven Nissen have been exposed for extreme conflicts of interest, drug “prostitution” and science denialism.

If you don’t realize that Big Pharma murders people to profit its profits, you have no idea what Big Pharma really is. Their entire business model is based on human suffering, exploitation and death.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fault Codes vs. Diagnosis: What's the Real Fix?

Updated Category News Views 8

When a Blink Isn’t the Whole Story Ever sat in your car, watched that check engine light flicker on, and felt your heart drop? Yeah, we've all been there. But here’s the kicker: just ‘cause that little demon’s glowing doesn’t mean your mechanic’s got all the answers. That’s where this HelloNation article steps in, trying to shed some light on the difference...

Continue Reading
Altitude+ and ViewLift Celebrate Record Fan Engagement

Updated Category News Views 38

Fresh Off the Bench: Altitude+ Rises Picture this: you're cruising through October, watching the leaves fall and the puck drop, and here come Altitude+ and ViewLift boasting some record numbers. This ain't your everyday puff piece — they've got concrete results to back it up. Altitude+, charging into the 2026–27 NHL and NBA seasons, isn't just surviving; they're...

Continue Reading
Venezuelan Crude Hits Texas: NABEP's Bold Move

Updated Category News Views 0

Venezuelan Crude Docking in Texas Signals New Energy Dynamics Batten down the hatches, 'cause NABEP's Venezuelan crude has made a splashy arrival in Texas. We're talking 1 million barrels, folks, the first of its kind under a fresh U.S. deal. This ain't your grandpa's oil shipment from the Middle East that takes forever to get here—nope, this crude made a pit stop in...

Continue Reading
Heart Attack vs. Cardiac Arrest: Know the Differences

Updated Category News Views 0

Spotting the Crisis: Heart Attack or Cardiac Arrest? When your heart’s in trouble, knowing whether it’s a heart attack or cardiac arrest isn’t just some medical trivia—it could save a life. According to healthcare whiz Justin Doss from Beaumont, Texas, this difference can be the thin line between life and a dire outcome. What's the Deal with These Heart Events?...

Continue Reading
Lincoln Educational Faces Class Action for Stock Drop

Updated Category News Views 68

What's Gripping Lincoln Educational Services? You ever feel like you've stepped into a financial thriller with these education stocks? Well, Lincoln Educational Services (NASDAQ:LINC) is at the heart of one, facing the heat of a class action lawsuit filed by Bleichmar Fonti & Auld LLP. It's all about securities fraud—a dreaded term that no investor wants to hear. The...

Continue Reading
Yuchai Eyes African Market Expansion with Strategic Visits

Updated Category News Views 65

Yuchai's Bold Move into Africa There's something gutsy about a company that doesn't just sit on its achievements but heads out into new territories. China Yuchai International (NYSE: CYD), a big player in powertrain solutions, recently embarked on a strategic tour across the African continent, a move that could well shape their future market playbook. East Africa:...

Continue Reading
Americans' Faith in Democracy Hits New Lows

Updated Category News Views 36

Polarization Beyond Politics: A National Reckoning When you catch wind of a report like this one, it's enough to make you feel like the fabric of democracy is unraveling right before our eyes. We're staring at a national identity crisis, folks, and it's got nothing to do with whether you're waving a red or blue flag. This ain't about party lines; it's about a bigger,...

Continue Reading
Franklin Financial Q3: 59% Net Income Surge Amid Growth

Updated Category News Views 80

Soaring Net Income and Impressive Growth Franklin Financial Services Corporation (NASDAQ: FRAF) seems to be on a roll this year, painting a vivid picture of growth as they close out the third quarter of 2026. With a strong surge in net income—59.4% up from Q3 2025—this leadership in earnings is no fluke. Net Income and Earnings per Share Let's break it down: the...

Continue Reading
Alpheus Explores LDH Kinetics as Glioblastoma Biomarker

Updated Category News Views 40

Cracking Glioblastoma's Tough Shell Some days, you're slogging through numbers that don't add up, and other times, you stumble upon findings that just might change the game. Alpheus Medical, diving headfirst into the murky waters of glioblastoma, dropped some intriguing data at the ESMO Congress 2026. This isn't your usual round of clinical discoveries, folks. What...

Continue Reading
Post University Expands with New Tech and Health Degrees

Updated Category News Views 56

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Investor Sentiment and Options for VRTX

Updated Category News Views 167

Current Trends in Vertex Pharmaceuticals Options Trading Recently, significant movements in the options trading for Vertex Pharmaceuticals have caught the attention of investors. The analysis reveals a mix of bullish and bearish strategies employed by traders in the market. This insight could be beneficial for those looking to understand how influential investors, often...

Continue Reading
Innovative Toilet Plunger Designed for Modern Households

Updated Category News Views 244

Transforming Toilet Maintenance with the POWER PLUNGER Invented by an inspired creator, the POWER PLUNGER is a revolutionary tool aimed at simplifying toilet unclogging for households. The inventor, drawing from personal experiences as a caregiver and a parent, recognized the frequent frustrations associated with clogged toilets. This unique plunger presents an effective...

Continue Reading
Acumen Pharmaceuticals Showcases Advances in Alzheimer's Treatments

Updated Category News Views 124

Acumen Pharmaceuticals to Present New Findings at AAIC 2025 Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering biopharmaceutical firm, is set to showcase groundbreaking findings at the Alzheimer’s Association International Conference (AAIC®) 2025. The company is dedicated to advancing innovative therapies aimed at targeting soluble amyloid beta oligomers (A?Os),...

Continue Reading
MAA Secures $400 Million in Senior Unsecured Notes Offering

Updated Category News Views 171

Mid-America Apartment Communities Announces Notes Offering Mid-America Apartment Communities, Inc. ("MAA") (NYSE: MAA) has successfully priced an impressive $400 million offering of senior unsecured notes. These 4.650% notes are due on January 15, 2033, following a strategic issuance from MAA's operating partnership, Mid-America Apartments, L.P. ("MAALP"). The notes were...

Continue Reading
Kompliant's Innovative Compliance Solutions Earn Global Recognition

Updated Category News Views 171

Kompliant Celebrated for Transforming Compliance in Financial Sector Kompliant, a leading name in compliance infrastructure, proudly announces its recent recognition in the esteemed FinTech Global's 2025 DataTech50 list. This prestigious list shines a light on the top fifty companies worldwide revolutionizing data management within the financial services industry....

Continue Reading